Comparison of Different Types of Oral Adsorbent Therapy in Patients with Chronic Kidney Disease: A Multicenter, Randomized, Phase IV Clinical Trial-Reference-Cited by-同舟云学术

Comparison of Different Types of Oral Adsorbent Therapy in Patients with Chronic Kidney Disease: A Multicenter, Randomized, Phase IV Clinical Trial

Published:2021 Issue:1 Volume:62 Page:41
ISSN:0513-5796
Container-title:Yonsei Medical Journal
language:en
Short-container-title:Yonsei Med J

Author:

Kee Youn Kyung¹^ORCID,Han Sang Youb²^ORCID,Kang Duk-Hee³^ORCID,Noh Jung Woo⁴^ORCID,Jeong Kyung Hwan⁵^ORCID,Kim Gheun-Ho⁶^ORCID,Kim Yang Wook⁷^ORCID,Kim Beom Seok⁸^ORCID

Affiliation:

1. Department of Internal Medicine, Kangdong Sacred Heart Hospital, Seoul, Korea.

2. Department of Internal Medicine, Ilsan-Paik Hospital, Inje University College of Medicine, Goyang, Korea.

3. Division of Nephrology, Department of Internal Medicine, Ewha Womans University School of Medicine, Ewha Medical Research Center, Seoul, Korea.

4. Department of Internal Medicine, Kangnam Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Korea.

5. Division of Nephrology, Department of Internal Medicine, Kyunghee University, Seoul, Korea.

6. Division of Nephrology, Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Korea.

7. Department of Internal Medicine, Haeundae Paik Hospital, Inje University College of Medicine, Busan, Korea.

8. Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.

Funder

Daewon Pharmaceutical Company

Publisher

Yonsei University College of Medicine

Subject

General Medicine

Link

https://eymj.org/pdf/10.3349/ymj.2021.62.1.41

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficient selective removal of uremic toxin precursor by olefin-linked covalent organic frameworks for nephropathy treatment;Nature Communications;2023-05-16

2. POTENTIAL THERAPEUTIC OPTIONS TARGETING THE GUT DYSBIOSIS IN CHRONIC KIDNEY DISEASE;Wiadomości Lekarskie;2022

3. Effect of Renamezin upon attenuation of renal function decline in pre-dialysis chronic kidney disease patients: 24-week prospective observational cohort study;PLOS ONE;2021-06-07